Literature DB >> 2478179

Prednisolone enhancement of primary endocrine anticancer treatment: a possible anti-angiogenic effect.

J T Beranek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2478179      PMCID： PMC2247353          DOI： 10.1038/bjc.1989.238

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  3 in total

1.  Heparin for prevention of atherosclerosis.

Authors:  A G Shulman
Journal:  N Engl J Med       Date:  1988-10-27       Impact factor: 91.245

2.  Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase.

Authors:  N T Chen; E J Corey; J Folkman
Journal:  Lab Invest       Date:  1988-10       Impact factor: 5.662

3.  Prednisolone improves the response to primary endocrine treatment for advanced breast cancer.

Authors:  R D Rubens; C L Tinson; R E Coleman; R K Knight; D Tong; P J Winter; W R North
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640
  3 in total
  1 in total

Review 1.  Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications.

Authors:  P R Colville-Nash; D L Scott
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.